
Hosting Singapore’s First Izon Exoid Workshop & Demo with NUSMed ncRNA Core
Atlantis Bioscience hosts Singapore’s first Izon Exoid Workshop with NUSMed ncRNA Core, showcasing TRPS technology for EV and nanoparticle analysis.
Atlantis Bioscience hosts Singapore’s first Izon Exoid Workshop with NUSMed ncRNA Core, showcasing TRPS technology for EV and nanoparticle analysis.
Join our free Exoid Workshop on 2 July 2025 at NUS to master EV, exosome & nanoparticle analysis with live demos and expert insights.
Explore the risks of using DMSO and protein-based cryoprotectants in cryopreservation of sensitive cells. Explore safer, xeno-free alternatives.
Join Atlantis Bioscience & Izon Science at ASPEV 2025 in Singapore, July 3–4 — showcasing the latest in EV research, tech, and global collaboration.
Discover how cell therapy stability requires multi-parametric assays beyond viability to preserve function, phenotype, and safety during storage and thaw.
Cryopreservation is a technique designed to preserve the viability and functionality of biological specimens, such as cells, tissues, and organs, by cooling them to subzero
Cell and gene therapies (CGTs), particularly autologous therapies like CAR-T/TCR-T cells, represent a breakthrough in personalized medicine. These treatments offer life-changing outcomes for patients with
Struggling to optimize AAV vectors for your gene therapy research? Let us engineer the solution! In collaboration with PackGene, our AAV Capsid Engineering service is
So, what exactly are AAVs? Adeno-associated viruses (AAVs) were first identified in 1965 by Bob Atchison and Wallace Rowe, who observed them as replication-defective particles
Induced pluripotent stem cells (iPSCs) have revolutionised the field of regenerative medicine, offering promising avenues for disease modelling, drug discovery, and potential therapeutic applications. However,
Summary Get an insightful overview of the burgeoning field of cell and gene therapies, showcasing their potential to revolutionize medical treatments. Discover the power of
Producing human Mesenchymal Stem Cells (MSCs) on a clinical scale is a complex endeavor, as there are no standardized optimal culture conditions universally adopted across
Find out strategies such as genetic engineering and modification of MSCs to enhance safety and efficacy of MSCs in cancer therapy.
Adoptive Cell Therapy (ACT) represents a promising approach for the treatment of cancer. It is a process in which immune cells such as T-cells
Contact our Customer Care, Sales & Scientific Assistance
Consult and asked questions about our products & services
Documentation of Technical & Safety Data Sheet, Guides and more...